The WHO tweeted that its technical advisory group had ruled that benefits of the shot, known as Covaxin, significantly outweighed the risks and that it met WHO standards for protection against Covid-19. The decision had been delayed as the advisory group sought additional clarifications from Bharat Biotech before conducting aContinue Reading